PharmaRise Holdings submitted its internal control report for fiscal year 40. The reporting period runs from 1 June 2025 to 31 May 2026, and the announcement materials were published on 20 August 2026.
The internal control report covers fiscal year 40, for the period from 1 June 2025 to 31 May 2026. The report submitted by PharmaRise Holdings can be viewed on Nikkei Company Information DIGITAL.
The announcement materials were published on 20 August 2026, with detailed information available through Nikkei Company Information DIGITAL. The information is supported by reporting from Nikkei.